Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by MSD naming Frances Fitzgerald .
Filed returns
21
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2024 | MSD | Health | Meetings to highlight the importance of predictability in IP rights in EU Pharmaceutical Legislation revision (Legislation) | 5 | On lobbying.ie |
| May–Aug 2023 | MSD | Health | EU Pharmaceutical Legislation (Legislation) | 7 | On lobbying.ie |
| Jan–Apr 2023 | MSD | Health | Revision of the European Pharmaceutical Legislation (Public policy or programme) | 17 | On lobbying.ie |
| May–Aug 2022 | MSD | Economic Development and Industry | Positioning Ireland in the Global Biopharmaceutical Industry (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2021 | MSD | Health | Cancer Care in a post-pandemic COVID-19 era (Public policy or programme) | 15 | On lobbying.ie |
| May–Aug 2021 | MSD | Health | Oncology Data Policy (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2021 | MSD | Health | Cancer Care in a post-pandemic COVID-19 era (Public policy or programme) | 18 | On lobbying.ie |
| Jan–Apr 2021 | MSD | Health | Oncology Policy (Public policy or programme) | 9 | On lobbying.ie |
| Sep–Dec 2020 | MSD | Health | Policy Priorities in a post-pandemic COVID-19 era (Public policy or programme) | 26 | On lobbying.ie |
| Sep–Dec 2020 | MSD | Health | Oncology Policy (Public policy or programme) | 34 | On lobbying.ie |
| May–Aug 2020 | MSD | Health | Oncology Policy (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2020 | MSD | Economic Development and Industry | Positioning Ireland in the Biopharmaceutical Industry (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2019 | MSD | Health | Oncology Policy (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2019 | MSD | Health | Oncology Policy (Public policy or programme) | 12 | On lobbying.ie |
| Jan–Apr 2019 | MSD | Economic Development and Industry | Development of the Pharmaceutical industry in Ireland (Public policy or programme) | 91 | On lobbying.ie |
| May–Aug 2018 | MSD | Health | Coordination on Oncology Medicines (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2018 | MSD | Health | Access to Medicines (Public policy or programme) | 6 | On lobbying.ie |
| Jan–Apr 2018 | MSD | Health | Immunisation Programmes (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2017 | MSD | Health | Access and Reimbursement of Medicines (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2017 | MSD | Health | Immunisation Programmes (Public policy or programme) | 19 | On lobbying.ie |
| Jan–Apr 2017 | MSD | Health | Immunisation Policy (Public policy or programme) | 18 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 18 | 85.7% | |
| Economic Development and Industry | 3 | 14.3% |